Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Phase II Trial of Celecoxib in Patients With Grade 2 or 3 Endometrioid-type, Clear Cell, and Papillary Serous Uterine Cancers

NCT00231829 is registered in ClinicalTrials.gov with Mark H. Einstein as lead sponsor.

NCT NCT00231829
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00231829 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Phase II Trial of Celecoxib in Patients With Grade 2 or 3 Endometrioid-type, Clear Cell, and Papillary Serous Uterine Cancers
Lead sponsor
Mark H. Einstein
Phase
Phase 2
Overall status
Terminated
Start date
April 30, 2003
Completion date
March 31, 2004
Enrollment
23
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

uterine cancer